streptomycin at 37 ºC in a humidified atmosphere of 5% CO 2 in 95% air. MEFs were passaged by trypsin (Invitrogen). mES cell line R1 (a gift from Professor N. Nakatsuji, Kyoto University) were maintained on Mitomycin C-treated MEFs in complete mESC culture medium (Millipore) consisting of DMEM/F12 (80%), knockout serum replacement (10%), fetal bovine serum (10%), L-glutamine (1 mM), nonessential amino acids (1%), "-mercaptoethanol (0.1 mM) and Leukemia inhibitory factor (1000 U/mL).
The medium was changed every day.
Treatment of SAHA-PIPs against MEF
MEF cells with in the passage P6 were trypsinized for 5 min at 37 °C, and were resuspended in the fresh DMEM medium to a concentration of 2 x 10 5 cells/ml in a 35 mm plate and were grown for 24 h as mentioned before 1, 3 . The medium was then removed and replaced with 2 ml of fresh DMEM medium followed by the addition of 2 !l of the 100 !M of each individual SAHA-PIP Q-" shown in Figure 1 to achieve a final polyamide concentration of 100 nM in 0.1% DMSO and then were incubated in a 5% CO 2 atmosphere at 37 °C for 24 h. 0.1% DMSO treated cells were used as the control. Incubation time and the concentration of the PI polyamide SAHA conjugates were standardized based on the initial optimization experiments with varied incubation time and the treatment of MEF with various concentration of SAHA-PIPs as mentioned before 1, 3 to optimize 100 nM as the optimal concentraion and 24 h as the optimal time for incubation.
Quantification of expression of marker genes in mouse embryonic fibroblasts treated with SAHA-PIP
As mentioned in the previous report 1 , total RNA was extracted from PI polyamide SAHA conjugates treated MEF using an RNeasy Mini Kit, in accordance with the manufacturer's instructions. The amount of nucleic acid in the total RNA was determined by measuring the absorbance at 260 nm using a NanoDrop spectrophotometer, ND-1000 (Thermo Scientific, USA) as mentioned before 1 . cDNA was synthesized from 500 ng of total RNA using a ReverTra Ace qPCR RT kit (Toyobo, Japan) and used as a template for polymerase chain reaction (PCR). SYBR green real-time RT-PCR amplifications were carried out in triplicate with THUNDERBIRD SYBR qPCR Mix (TOYOBO, Japan) and the program as mentioned before 1 . Melting curve analysis of amplification products and the comparative cycle threshold (CT) method used to analyze the expression level of each gene was as carried out as mentioned before 1 . The average CT of the three determinations was used in calculations of relative expression level using DMSO treated cells as the internal control. The relative expression of genes was normalized against GAPDH. Primer pairs of iPSC factors and actin that were used for RT-PCR analysis is as shown 4 .
Other primer pairs used to analyze endogenous gene expression were listed in Table S4 .
Chromatin immunoprecipitation (ChIP) analysis of promoter region of pluripotency genes
Antibodies for acetylated histone H3 and normal rabbit IgG were purchased from Upstate Biotechnology Inc., USA and H3K14 was purchased from Abcam (ab10812, UK). ES cells were used as the positive control. After 24 h treatment of each of the cells individually with 100 nM of !, !-OMe, B, SAHA and 0.1 % DMSO, ChIP assay was performed according to the protocol described in 5 and that in the kit manual (SimpleChIP™ Enzymatic Chromatin IP Kit, Cell Signaling Technology, USA). DNA fraction was then purified QIAquick PCR Purification Kit (Qiagen, USA) and analyzed with qRT-PCR as mentioned before. Input sample was used as the internal control and the GAPDH was used as the internal control primer pair. Details of the purchased primer pairs used for Oct Nanog, Rex1, Dppa4, Gapdh and Cdh1 were shown in Table S5 . 
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